HireRight Holdings Statistics
Total Valuation
HRT has a market cap or net worth of $967.19 million. The enterprise value is $1.62 billion.
| Market Cap | 967.19M |
| Enterprise Value | 1.62B |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, after market close.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
HRT has 67.35 million shares outstanding. The number of shares has decreased by -12.85% in one year.
| Shares Outstanding | 67.35M |
| Shares Change (YoY) | -12.85% |
| Shares Change (QoQ) | -7.10% |
| Owned by Insiders (%) | 0.64% |
| Owned by Institutions (%) | 98.27% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 9.99 |
| PS Ratio | 1.34 |
| Forward PS | 1.24 |
| PB Ratio | 2.15 |
| P/FCF Ratio | 13.78 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.95, with an EV/FCF ratio of 23.09.
| EV / Earnings | n/a |
| EV / Sales | 2.25 |
| EV / EBITDA | 10.95 |
| EV / EBIT | 25.86 |
| EV / FCF | 23.09 |
Financial Position
The company has a current ratio of 1.76, with a Debt / Equity ratio of 1.63.
| Current Ratio | 1.76 |
| Quick Ratio | 1.59 |
| Debt / Equity | 1.63 |
| Debt / EBITDA | 4.94 |
| Debt / FCF | 10.41 |
| Interest Coverage | 0.89 |
Financial Efficiency
Return on equity (ROE) is -1.50%.
| Return on Equity (ROE) | -1.50% |
| Return on Assets (ROA) | -0.50% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $225,590 |
| Profits Per Employee | -$2,169 |
| Employee Count | 3,190 |
| Asset Turnover | 0.47 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -445,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +27.64% in the last 52 weeks. The beta is 0.78, so HRT's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | +27.64% |
| 50-Day Moving Average | 14.33 |
| 200-Day Moving Average | 12.78 |
| Relative Strength Index (RSI) | 56.52 |
| Average Volume (20 Days) | 293,517 |
Short Selling Information
The latest short interest is 375,487, so 0.56% of the outstanding shares have been sold short.
| Short Interest | 375,487 |
| Short Previous Month | 302,633 |
| Short % of Shares Out | 0.56% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.92 |
Income Statement
In the last 12 months, HRT had revenue of $719.63 million and -$6.92 million in losses. Loss per share was -$0.10.
| Revenue | 719.63M |
| Gross Profit | 350.45M |
| Operating Income | 62.30M |
| Pretax Income | -7.37M |
| Net Income | -6.92M |
| EBITDA | 148.07M |
| EBIT | 62.68M |
| Loss Per Share | -$0.10 |
Balance Sheet
The company has $77.29 million in cash and $730.96 million in debt, giving a net cash position of -$653.67 million or -$9.71 per share.
| Cash & Cash Equivalents | 77.29M |
| Total Debt | 730.96M |
| Net Cash | -653.67M |
| Net Cash Per Share | -$9.71 |
| Equity (Book Value) | 449.81M |
| Book Value Per Share | 6.68 |
| Working Capital | 99.05M |
Cash Flow
In the last 12 months, operating cash flow was $86.01 million and capital expenditures -$15.81 million, giving a free cash flow of $70.20 million.
| Operating Cash Flow | 86.01M |
| Capital Expenditures | -15.81M |
| Free Cash Flow | 70.20M |
| FCF Per Share | $1.04 |
Margins
Gross margin is 48.70%, with operating and profit margins of 8.66% and -0.96%.
| Gross Margin | 48.70% |
| Operating Margin | 8.66% |
| Pretax Margin | -1.02% |
| Profit Margin | -0.96% |
| EBITDA Margin | 20.58% |
| EBIT Margin | 8.71% |
| FCF Margin | 9.75% |
Dividends & Yields
HRT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 12.85% |
| Shareholder Yield | 12.85% |
| Earnings Yield | -0.72% |
| FCF Yield | 7.26% |
Analyst Forecast
The average price target for HRT is $12.00, which is -16.43% lower than the current price. The consensus rating is "Hold".
| Price Target | $12.00 |
| Price Target Difference | -16.43% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HRT has an Altman Z-Score of 1.04 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.04 |
| Piotroski F-Score | 4 |